Navigating Neurological Biomarker Research

Protein biomarkers are transforming neurodegenerative disease research—offering new ways to guide detection, monitoring, and understanding conditions such as Alzheimer’s and Parkinson’s. Yet turning biomarker discoveries into clinically meaningful insights remains a complex challenge for neurology researchers and biopharma teams.

Informed by a roundtable with leading experts from academia and biopharma, this in-depth white paper explores what’s working, what challenges persist, and how biomarker strategies are advancing precision neurology. Discover practical lessons from real-world research and learn how proteomics is accelerating progress from discovery to translational relevance.

In this white paper, you’ll learn:

• Key emerging biomarkers shaping neurodegeneration research
• Best practices for integrating proteomics into clinical and translational studies
• Real-world examples of biomarker-driven research across diverse cohorts and longitudinal studies

Optimize your neurology research strategy with expert perspectives designed to support your studies from biomarker discovery to clinical translation.